β CrossMark Policy
CrossMark is a trusted multi-publisher initiative developed by Crossref to help readers identify the most current, accurate, and authoritative version of scholarly content.
By displaying the CrossMark logo on published articles, GSC Biological and Pharmaceutical Sciences (GSCBPS) demonstrates its commitment to scholarly integrity, publication transparency, content accuracy, and the long-term reliability of the scientific record.
π What Information Does CrossMark Provide?
When readers click the CrossMark logo displayed on a GSCBPS article, they can:
- β Verify the current publication status of the article
- π Access corrections, updates, amendments, or retraction notices, where applicable
- π Review additional publication record information associated with the article
- π Confirm whether they are viewing the latest authoritative version of the scholarly work
π Scope of the CrossMark Policy
The CrossMark logo may apply to current and future journal content and is limited to publication types designated by GSCBPS. Its use supports transparent scholarly communication and helps readers track important changes made after publication.
For additional information about CrossMark and its role in maintaining the scholarly record, visit the official Crossref CrossMark information page.
π CrossMark Policy Page DOI: 10.30574/gscbps.ourcrossmarkpolicy
π CrossMark Policy Page DOI URL: https://doi.org/10.30574/gscbps.ourcrossmarkpolicy
βοΈ Correction, Expression of Concern, and Retraction Policy
GSC Biological and Pharmaceutical Sciences (GSCBPS) is committed to maintaining high standards of publication ethics, research integrity, editorial transparency, and accuracy throughout the scholarly publishing process.
When an error, ethical concern, or reliability issue is identified after publication, the journal may issue an appropriate post-publication notice depending on the seriousness and nature of the matter.
π Types of Post-Publication Notices
- βοΈ Erratum or Correction β issued to correct minor errors that do not materially affect the scientific conclusions, validity, or integrity of the published article.
- β οΈ Expression of Concern β issued when serious questions have been raised regarding the reliability, ethics, authorship, data, or integrity of a published article and further investigation is required.
- π« Retraction Notice β issued when a published article is found to contain major errors, unreliable findings, plagiarism, duplicate publication, ethical violations, fabricated or falsified data, or other serious breaches of publication standards.
π Transparency and Permanent Record
All corrections, expressions of concern, and retraction notices are handled in accordance with recognized scholarly publishing standards and relevant guidance from the Committee on Publication Ethics (COPE).
Any post-publication notice issued by GSCBPS will be clearly identified and permanently linked to the original article. The original scholarly record will be preserved wherever appropriate to ensure transparency, accountability, and long-term accessibility.
GSCBPS may also update the article metadata, Crossref record, DOI information, indexing information, and article webpage to reflect the current publication status.
π© Reporting Errors or Publication Concerns
Authors, readers, reviewers, institutions, and other interested parties may report possible errors, ethical concerns, or publication-integrity issues to the GSCBPS Editorial Office. Reports should include the article title, DOI, relevant evidence, and a clear description of the concern.
For further assistance, contact the Editorial Office at editor-gscbps@gsconlinepress.com.
β Frequently Asked Questions About the CrossMark, Correction and Retraction Policy
1. What is the CrossMark Policy of GSC Biological and Pharmaceutical Sciences (GSCBPS)?
The CrossMark Policy explains how GSCBPS helps readers identify the current and authoritative version of a published article through the Crossref CrossMark service. For complete details, visit the π CrossMark Policy section.
2. What is CrossMark?
CrossMark is a Crossref service that enables readers to verify whether they are viewing the latest version of a scholarly article and access any available updates or corrections. For complete details, visit the π CrossMark Policy section.
3. Why does GSCBPS use CrossMark?
GSCBPS uses CrossMark to promote publication transparency, maintain the integrity of the scholarly record, and help readers identify important article updates.
4. What happens if an error is found after publication?
Depending on the nature and seriousness of the issue, GSCBPS may publish a correction, expression of concern, or retraction notice.
5. What is the difference between a correction and a retraction?
A correction addresses errors that do not invalidate the research, while a retraction is issued when an article contains major errors, unreliable findings, or serious ethical violations.
6. When does GSCBPS issue an Expression of Concern?
An Expression of Concern may be issued when significant questions arise regarding the reliability, ethics, data, or integrity of a published article while further investigation is required..
7. Are correction and retraction notices linked to the original article?
Yes. Any correction, expression of concern, or retraction notice is permanently linked to the original article to maintain transparency and preserve the scholarly record.
8. Can authors request a correction to a published article?
Yes. Authors may contact the Editorial Office if they identify an error in a published article. Each request is reviewed according to the journalβs editorial and ethical policies.
9. Does GSCBPS follow international publication ethics when issuing corrections or retractions?
Yes. GSCBPS follows recognized scholarly publishing standards and considers relevant guidance from the Committee on Publication Ethics when handling post-publication issues.
10. How can I report an error or publication concern to GSCBPS?
Authors, readers, reviewers, institutions, and other concerned parties may report an issue by contacting the Editorial Office and providing the article title, DOI, supporting evidence, and a clear description of the concern. For complete details, visit the π© Contact Us page.